APAC CIO Outlook
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Agile

    AI Healthcare

    Artificial Intelligence

    Aviation

    Bi and Analytics

    Big Data

    Cloud

    Cyber Security

    Digital Infrastructure

    Digital Marketing

    Digital Transformation

    Digital Twin

    Drone

    Internet of Things

    Low Code No Code

    Networking

    Remote Work

    Smart City

    Startup

    Unified Communication

    Wireless

  • E-Commerce

    Education

    FinTech

    Healthcare

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • Dell

    IBM

    Microsoft

    Salesforce

    SAP

  • Cognitive

    Compliance

    Contact Center

    Corporate Finance

    Data Center

    Data Integration

    Digital Asset Management

    Full Stack Development

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Proptech

    RegTech

Menu
    • AI
    • Compliance
    • IBM
    • Big Data
    • Unified Communication
    • Digital Infrastructure
    • Data Center
    • Salesforce
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • Artificial Intelligence
    Editor's Pick (1 - 4 of 8)
    left
    The Right Technology And Reliable Partners; The Business Next Frontier

    Luke O'Brien, CIO, ISS Facility Services Australia & New Zealand

    Conquering Technological Transformation

    David Kennedy, Group CIO, Transaction Services Group

    How to Get to AI-first

    Ani Paul, CIO, ING Australia

    Legal Knowledge Management and the Rise of Artificial Intelligence

    Christopher Zegers, CIO, Lowenstein Sandler LLP

    Building an AI-Based Machine Learning for Global Economics

    Alexander Fleiss, CIO & CEO, Rebellion Research Partners LP

    Doing Analytics vs Scaling Analytics

    Ram Thilak, Global Head of Data Science and Analytics, Inchcape PLC

    The City of the Future Is Connected, Resilient, and Sustainable

    Chew Men Leong, President/Head, Urban Solutions, ST Engineering

    Changing the tester DNA -From tester to Software Development Engineer in Test (SDET)

    Bernd Bornhausen, Senior Manager QA, TD Insurance [NYSE: TD]

    right

    Insilico Forms Research Collaboration with Taisho

    Tweet

    Insilico Medicine and Taisho Pharmaceutical have entered into a research collaboration to find novel therapeutics against aging.

    Fremont, CA: Insilico Medicine and Taisho Pharmaceutical have entered into a research collaboration to find novel therapeutics against aging. Insilico will utilize both the target discovery and generative chemistry parts of its Pharma.AI platform in this collaboration. The firm will also use its proprietary Pandomics Discovery Platform to identify novel targets for senolytic drugs and Chemistry42 platform for a molecular generation. This new collaboration brings together Insilico's state-of-art artificial intelligence (AI) technologies in drug discovery with Taisho's expertise in drug development, mainly focused on extending human healthspan.

    "We're delighted to collaborate with Taisho pharmaceutical, a well-recognized leader in the pharmaceutical industry and healthcare sector. It is believed that aging is a universal phenomenon that we cannot stop. However, emerging scientific evidence has shown that one may be able to reverse some of the age-associated processes. Through this collaboration, we will adopt our AI-powered drug discovery suites together with Taisho's validation platform to explore the new space of anti-aging solutions," said Jimmy Yen-Chu Lin, Ph.D., CEO of Insilico Medicine Taiwan, a fully-owned subsidiary of Insilico Medicine

    Under the terms of the collaboration agreement, Insilico will receive an upfront payment and milestone payments upon achieving specified goals. The firm will be responsible for the early research phase target identification and molecular generation. Taisho will work collaboratively with Insilico in validating the results in various in vitro and in vivo assays. Taisho has the exclusive option to acquire Insilico's co-ownership of the successfully developed programs under the agreed payment.

    "It is our great honor to be collaborating with the scientists of Taisho Pharmaceutical, one of the top 100 pharmaceutical companies in the world operating since 1912. The high level of the scientists we are interfacing, and our previous successes in the application of the Pharma.AI platform for discovery of novel targets and molecules in fibrosis, and previous experience in senolytic drug discovery give us confidence that this collaboration will be successful," said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine.

    tag

    Pharmaceutical

    Weekly Brief

    loading
    Top 10 AI Powered Solution Companies - 2021

    Featured Vendors

    Silverpond

    Jonathan Chang, Director

    Top 10 AI Powered Solution Companies - 2021
    ON THE DECK

    AI 2021

    Top Vendors

    AI 2020

    Top Vendors

    AI 2019

    Top Vendors

    AI 2018

    Top Vendors

    AI 2017

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Loading...

    Copyright © 2022 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    |  Sitemap |  Subscribe |   About us

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://artificial-intelligence.apacciooutlook.com/press-release/insilico-forms-research-collaboration-with-taisho-nwid-7797.html